Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Medioni

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Addiction (Abingdon, England)|February 1, 2005
Increased risk of relapse after stopping nicotine replacement therapies: a mathematical modelling approachJacques Medioni, Ivan Berlin, Alain Mallet
Bulletin Du Cancer|November 4, 2005
[Prostate cancer: update]Stéphane Oudard, Jacques Medioni, Florian Scotté, et al.
Medical Oncology (Northwood, London, England)|May 16, 2009
Olecranon bursitis in patients treated with sunitinib for renal cell carcinomaThomas Gregory, Olivier Mir, Jacques Medioni, et al.
Bulletin Du Cancer|July 1, 2011
[Targeting the RAS signalling pathway in cancer]Laura Mansi, Erika Viel, Elsa Curtit, et al.
Presse Medicale (Paris, France : 1983)|December 28, 2007
[Chemotherapy for prostate cancer]Jacques Medioni, Dimitri Dionysopoulos, Eugéniu Banu, et al.
Contemporary Clinical Trials|November 23, 2006
Phase II multi-step planning methods in oncology: comparison, recommendations and potential applicationsJacques Medioni, Yann de Rycke, Caroline Tournoux Facon, et al.
Bulletin Du Cancer|September 13, 2007
[New targeted therapies in hormone-refractory prostate cancer]Stéphane Oudard, Eugeniu Banu, Florian Scotte, et al.
Cardiovascular and Interventional Radiology|October 5, 2013
Management of painful pelvic bone metastasis of renal cell carcinoma using embolization, radio-frequency ablation, and cementoplasty: a prospective evaluation of efficacy and safetyOlivier Pellerin, Jacques Medioni, Claire Vulser, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Innovative design for a phase 1 trial with intra-patient dose escalation: The Crotoxin studyJacques Medioni, Mara Brizard, Reza Elaidi, et al.
Clinical Breast Cancer|February 27, 2017
French Medico-Administrative Data to Identify the Care Pathways of Women With Breast CancerDelphine Lefeuvre, Christine Le Bihan-Benjamin, Iris Pauporté, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Addiction (Abingdon, England)|February 1, 2005
Increased risk of relapse after stopping nicotine replacement therapies: a mathematical modelling approachJacques Medioni, Ivan Berlin, Alain Mallet
Bulletin Du Cancer|November 4, 2005
[Prostate cancer: update]Stéphane Oudard, Jacques Medioni, Florian Scotté, et al.
Medical Oncology (Northwood, London, England)|May 16, 2009
Olecranon bursitis in patients treated with sunitinib for renal cell carcinomaThomas Gregory, Olivier Mir, Jacques Medioni, et al.
Bulletin Du Cancer|July 1, 2011
[Targeting the RAS signalling pathway in cancer]Laura Mansi, Erika Viel, Elsa Curtit, et al.
Presse Medicale (Paris, France : 1983)|December 28, 2007
[Chemotherapy for prostate cancer]Jacques Medioni, Dimitri Dionysopoulos, Eugéniu Banu, et al.
Contemporary Clinical Trials|November 23, 2006
Phase II multi-step planning methods in oncology: comparison, recommendations and potential applicationsJacques Medioni, Yann de Rycke, Caroline Tournoux Facon, et al.
Bulletin Du Cancer|September 13, 2007
[New targeted therapies in hormone-refractory prostate cancer]Stéphane Oudard, Eugeniu Banu, Florian Scotte, et al.
Cardiovascular and Interventional Radiology|October 5, 2013
Management of painful pelvic bone metastasis of renal cell carcinoma using embolization, radio-frequency ablation, and cementoplasty: a prospective evaluation of efficacy and safetyOlivier Pellerin, Jacques Medioni, Claire Vulser, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Innovative design for a phase 1 trial with intra-patient dose escalation: The Crotoxin studyJacques Medioni, Mara Brizard, Reza Elaidi, et al.
Clinical Breast Cancer|February 27, 2017
French Medico-Administrative Data to Identify the Care Pathways of Women With Breast CancerDelphine Lefeuvre, Christine Le Bihan-Benjamin, Iris Pauporté, et al.
Pageof 6